8-K - Kyverna Therapeutics, Inc. | StockGist

Current Report Details

Event Type

Management Change

Other Event

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Resignation o

Management Change

Company relating to any of the Company

8.01

Other Events. On February 3, 2026, the Company issued a press release announcing the appointment of Mayo Pujols as the Company’s Chief Technology Officer, effec

Other Event

9.01

Financial Statements and Exhibits (d) Exhibits. Number Description 10.1 Kyverna Therapeutics, Inc. Amended and Restated 2024 Inducement Equity Incentive Plan. 9

Exhibits Only

Source Document

Exhibits (3)

10.1

EX-10.1

8-K

99.1

EX-99.1